Skip to main content
. 2016 Jun 16;116:1627–1638. doi: 10.1007/s00421-016-3412-0

Table 4.

Comparison of the three tests (in the comparison group)

Measured VO2max (L min−1) Estimated VO2max (L min−1) Difference measured vs. estimated VO2max (L min−1)
EB-testnew EB-test2012 Åstrand EB-testnew EB-test2012 Åstrand
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (95 % CI) Mean (95 % CI) Mean (95 % CI)
All (n = 71) 3.17 (0.67) 3.14 (0.71) 3.30 (0.66) 3.10 (0.79) −0.03 (−0.10 to 0.04) 0.12 (0.04 to 0.21) −0.07 (−0.21 to 0.06)
Men (n = 27) 3.70 (0.55) 3.79 (0.53) 3.89 (0.33) 3.29 (0.75) 0.09 (−0.03 to 0.21) 0.20 (0.05 to 0.34) −0.41 (−0.61 to −0.20)
Women (n = 44) 2.85 (0.53) 2.74 (0.47) 2.93 (0.54) 2.98 (0.80) −0.11 (−0.19 to −0.03) 0.08 (−0.02 to 0.18) 0.13 (−0.02 to 0.28)
Age
 <35 (n = 41) 3.41 (0.50) 3.37 (0.56) 3.54 (0.43) 3.37 (0.66) −0.04 (−0.13 to 0.06) 0.14 (0.03 to 0.24) −0.04 (−0.23 to 0.14)
 35–49 (n = 17) 2.97 (0.67) 2.91 (0.72) 3.06 (0.56) 2.81 (0.80) −0.06 (−0.21 to 0.09) 0.10 (−0.04 to 0.24) −0.15 (−0.48 to 0.17)
 50–64 (n = 12) 2.75 (0.86) 2.77 (0.89) 2.86 (1.01) 2.69 (0.85) 0.02 (−0.19 to 0.23) 0.11 (−0.23 to 0.45) −0.06 (−0.36 to 0.24)
Absolute VO2max level (according to L min−1)
 Q1 (n = 10) 2.19 (0.43) 2.36 (0.55) 2.52 (0.74) 2.24 (0.55) 0.16 (−0.05 to 0.37) 0.32 (0.00 to 0.64) 0.05 (−0.33 to 0.42)
 Q2 (n = 15) 3.00 (0.47) 3.08 (0.68) 3.37 (0.62) 2.67 (0.62) 0.08 (−0.08 to 0.24) 0.37 (0.21 to 0.53) −0.33 (−0.62 to −0.05)
 Q3 (n = 23) 3.41 (0.67) 3.38 (0.80) 3.49 (0.69) 3.22 (0.67) −0.03 (−0.14 to 0.09) 0.08 (−0.07 to 0.23) −0.18 (−0.39 to 0.02)
 Q4 (n = 23) 3.47 (0.41) 3.27 (0.44) 3.40 (0.35) 3.63 (0.62) −0.20 (−0.31 to −0.10) −0.08 (−0.16 to 0.01) 0.15 (−0.12 to 0.43)
Relative VO2max level (according to mL kg−1 min−1)
 Q1 (n = 11) 2.84 (0.79) 2.93 (0.72) 3.25 (0.77) 2.61 (0.55) 0.09 (−0.07 to 0.25) 0.40 (0.25 to 0.56) −0.24 (−0.73 to 0.25)
 Q2 (n = 12) 2.94 (0.82) 2.98 (0.89) 3.08 (0.96) 2.84 (0.87) 0.03 (−0.14 to 0.21) 0.14 (−0.10 to 0.38) −0.10 (−0.37 to 0.16)
 Q3 (n = 25) 3.21 (0.62) 3.20 (0.79) 3.34 (0.65) 3.01 (0.75) −0.01 (−0.16 to 0.14) 0.13 (−0.02 to 0.28) −0.19 (−0.42 to 0.03)
 Q4 (n = 23) 3.41 (0.50) 3.25 (0.50) 3.38 (0.40) 3.56 (0.67) −0.15 (−0.25 to −0.06) −0.03 (−0.16 to 0.11) 0.15 (−0.08 to 0.39)
Coefficient of variation R2 adjusted SEE
EB-testnew (%) EB-test2012 (%) Åstrand (%) EB-testnew EB-test2012 Åstrand EB-testnew EB-test2012 Åstrand
All (n = 71) 9.4 10.9 18.1 0.83 0.74 0.50 0.28 0.35 0.48
Men (n = 27) 8.4 9.7 14.8 0.68 0.56 0.50 0.31 0.36 0.39
Women (n = 44) 9.3 11.8 17.2 0.75 0.62 0.61 0.26 0.32 0.33
Age
 <35 (n = 41) 8.8 9.5 17.3 0.71 0.57 0.25 0.27 0.33 0.44
 35–49 (n = 17) 9.9 9.1 21.7 0.83 0.82 0.38 0.28 0.28 0.52
 50–64 (n = 12) 11.9 19.0 17.2 0.85 0.70 0.69 0.33 0.47 0.47
Absolute VO2max level (according to L min−1)
 Q1 (n = 10) 12.8 18.8 23.9 0.69 0.67 0.08 0.24 0.24 0.41
 Q2 (n = 15) 9.7 9.2 18.2 0.86 0.78 0.29 0.17 0.22 0.39
 Q3 (n = 23) 8.0 10.1 14.5 0.89 0.75 0.53 0.22 0.34 0.46
 Q4 (n = 23) 7.3 5.7 17.7 0.69 0.76 0.06 0.23 0.20 0.40
Relative VO2max level (according to mL kg−1 min−1)
 Q1 (n = 11) 8.2 7.8 26.9 0.91 0.90 0.12 0.25 0.25 0.75
 Q2 (n = 12) 9.3 12.5 14.6 0.90 0.84 0.75 0.27 0.33 0.41
 Q3 (n = 25) 11.3 10.9 17.4 0.79 0.70 0.47 0.28 0.34 0.45
 Q4 (n = 23) 6.6 9.2 15.5 0.81 0.59 0.34 0.22 0.32 0.41

All measured and estimated values are in expressed as L min−1

Quartiles (L min−1), women; <2.14, 2.14–2.59, 2.59–2.93, >2.93; men; <3.07, 3.07–3.75, 3.75–4.33, >4.33

Quartiles (mL kg−1 min−1), women; <32.5, 32.5–40.2, 40.2–47.4, >47.4; men; <37.5, 37.5–47.6, 47.6–54.8, >54.8

SD standard deviation, SEE standard error of the estimate, Q quartile